Applied dna receives clia certification, enabling high throughput diagnostic covid-19 testing

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (applied dna or the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that its applied dna clinical labs, llc (adcl) subsidiary received clia (clinical laboratory improvement amendments) certification from the new york state department of health clinical laboratory evaluation program (clep) for covid-19 testing using eua-authorized methods and devices. with this certifica
APDN Ratings Summary
APDN Quant Ranking